Search Results - "Averell, Carlyne"

Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs by Averell, Carlyne M., Stanford, Richard H., Laliberté, François, Wu, Jennifer W., Germain, Guillaume, Duh, Mei Sheng

“…This real-world observational study compared medication adherence and persistence among patients with asthma receiving the once-daily inhaled…”
Get full text

The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States by Bell, Christopher F, Huang, Shirley P, Cyhaniuk, Anissa, Averell, Carlyne M

“…Objective Assess healthcare costs associated with systemic lupus erythematosus (SLE) flares among patients with and without lupus nephritis (LN). Methods This…”
Get full text

Healthcare resource utilization and costs in patients with a newly confirmed diagnosis of lupus nephritis in the United States over a 5-year follow-up period by Bell, Christopher F, Wu, Benjamin, Huang, Shirley P, Rubin, Bernard, Averell, Carlyne M, Chastek, Benjamin, Hulbert, Erin M

“…We aimed to describe healthcare resource utilization (HCRU) and healthcare costs in patients with newly confirmed lupus nephritis (LN) in the United States…”
Get full text

Disease burden and treatment adherence among children and adolescent patients with asthma by Averell, Carlyne M., Laliberté, François, Germain, Guillaume, Slade, David J., Duh, Mei S., Spahn, Joseph

“…To assess asthma burden and medication adherence in a US de-identified patient level claims database. This retrospective observational study used the IQVIA…”
Get full text

Real-world users of triple therapy for asthma in the US by Hansel, Nadia N, Abbott, Carl B, Averell, Carlyne M, Germain, Guillaume, Laliberté, François, Mahendran, Malena, Duh, Mei S, Settipane, Russell A

“…For patients with asthma who remain symptomatic on a medium-dose inhaled corticosteroid/long-acting β2 agonist, addition of a long-acting muscarinic antagonist…”
Get full text

Symptom control in patients with asthma using inhaled corticosteroids/long-acting β2-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study by Averell, Carlyne M., Laliberté, François, Germain, Guillaume, Duh, Mei Sheng, Lima, Robson, Mahendran, Malena, Slade, David J.

“…Treatment with fluticasone furoate/vilanterol (FF/VI), an inhaled corticosteroid/long-acting β 2 -agonist therapy, reduces the risk of severe asthma…”
Get full text

Real-world evidence: Patient views on asthma in respiratory specialist clinics in America by Oppenheimer, John, Slade, David J, Hahn, Beth A, Zografos, Laurie, Gilsenan, Alicia, Richardson, David, McSorley, David, Lima, Robson, Molfino, Nestor A, Averell, Carlyne M

“…Approximately 30% to 50% of patients with moderate/severe asthma have inadequately controlled disease despite adherence to inhaled corticosteroid…”
Get full text

Symptom control in patients with asthma using inhaled corticosteroids/long-acting β 2 -agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study by Averell, Carlyne M, Laliberté, François, Germain, Guillaume, Duh, Mei Sheng, Lima, Robson, Mahendran, Malena, Slade, David J

“…Treatment with fluticasone furoate/vilanterol (FF/VI), an inhaled corticosteroid/long-acting β -agonist therapy, reduces the risk of severe asthma…”
Get full text

Health Care Costs With Sustained Oral Corticosteroid Use in Systemic Lupus Erythematosus by Huang, Shirley P., DerSarkissian, Maral, Gu, Yuqian M., Duh, Mei Sheng, Wang, Min-Jung, Benson, John, Vu, Jensen Duy, Averell, Carlyne M., Bell, Christopher F.

“…The goal of this study was to compare health care costs, health care resource utilization, and adverse events associated with sustained oral corticosteroid…”
Get full text

Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management by Busse, William W., Abbott, Carl B., Germain, Guillaume, Laliberté, François, MacKnight, Sean D., Jung, Young, Duh, Mei Sheng, Averell, Carlyne M.

“…Treatment guidelines recommend triple therapy for patients with asthma who remain uncontrolled on inhaled corticosteroid/long-acting β2-agonist therapy…”
Get full text

Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States by Averell, Carlyne M., Laliberté, François, Germain, Guillaume, Duh, Mei Sheng, Rousculp, Matthew D., MacKnight, Sean D., Slade, David J.

“…Background: Suboptimal adherence to maintenance medication has been associated with poor outcomes in asthma. This study examined single-inhaler inhaled…”
Get full text

A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA by Bell, Christopher F., Huang, Shirley P., Yu, Louise H., DerSarkissian, Maral, Germain, Guillaume, Concoff, Andrew L., Averell, Carlyne M., Rubin, Bernard, Gu, Yuqian M., Duh, Mei Sheng, Wallace, Daniel J.

“…Introduction We evaluated the use of rheumatoid arthritis (RA) disease measures in patients with systemic lupus erythematosus (SLE) in a US community-based…”
Get full text

Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid/Long-Acting β-Agonist for Asthma by Stanford, Richard H., Averell, Carlyne, Parker, Emily D., Blauer-Peterson, Cori, Reinsch, Tyler K., Buikema, Ami R.

“…Although efficacy and safety of fluticasone furoate/vilanterol (FF/VI) and budesonide/formoterol (BUD/F) have been demonstrated in clinical studies, real-world…”
Get full text

Treatment Patterns and Disease Burden Associated with Multiple-Inhaler Triple-Therapy Use in Asthma by Oppenheimer, John, Bogart, Michael, Bengtson, Lindsay G.S., White, John, Sundquist, Kevin, Lima, Robson, Averell, Carlyne

“…Addition of a long-acting muscarinic antagonist is recommended for patients with asthma uncontrolled on inhaled corticosteroid/long-acting β2-agonist therapy…”
Get full text

Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study by Huang, Shirley P., Guisinger, Amy, Averell, Carlyne, Bell, Christopher F., Rubin, Bernie

“…Introduction This study aimed to describe the clinical burden, healthcare resource utilisation (HCRU) and healthcare costs for patients with systemic lupus…”
Get full text

Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis by Bell, Christopher F, Wu, Benjamin, Huang, Shirley P, Rubin, Bernard, Averell, Carlyne M, Chastek, Benjamin, Hulbert, Erin M, Von Feldt, Joan

“…Lupus nephritis (LN) is among the most severe organ manifestations of systemic lupus erythematosus (SLE), affecting between 31% and 48% of patients, usually…”
Get full text

Characteristics of Treated Asthmatics Experiencing Exacerbations in a US Database: A Retrospective Cohort Study by Averell, Carlyne M, Hinds, David, Fairburn-Beech, Jolyon, Wu, Benjamin, Lima, Robson

“…The National Heart, Lung, and Blood Institute (NHLBI) recommend a stepwise approach to asthma management, with the goals of maintaining asthma control and…”
Get full text

Observational vignette study to examine patient and healthcare provider perceived impact of asthma-related exacerbations in the US by Johnson, Phaedra T, Bell, Christopher F, White, John, Essoi, Breanna, Nelsen, Linda, Averell, Carlyne M

“…Little is known about how patients and healthcare providers (HCPs) perceive the impact of asthma-related exacerbations. This study examined the impact of…”
Get full text

Characterizing Real-World Use Of Tiotropium In Asthma In The USA by Averell, Carlyne M, Laliberté, François, Duh, Mei Sheng, Wu, Jennifer W, Germain, Guillaume, Faison, Sarai

“…Tiotropium bromide (TIO) is a long-acting muscarinic antagonist recommended as an add-on therapy option for patients with uncontrolled asthma on inhaled…”
Get full text

Observational vignette study to examine patient and healthcare provider perceived impact of asthma-related exacerbations in the US by Johnson, Phaedra T., Bell, Christopher F., White, John, Essoi, Breanna, Nelsen, Linda, Averell, Carlyne M.

“…Background: Little is known about how patients and healthcare providers (HCPs) perceive the impact of asthmarelated exacerbations. This study examined the…”
Get full text